EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

FLOW: Flow dysfunction of hemodialysis vascular access: A randomized controlled trial on the effectiveness of surveillance of arteriovenous fistulas and grafts

Bianca Zomer iD, Matthijs S Ruiter iD, Friedo W Dekker, Ellen Gd Goertz, Michiel W de Haan, Marc Hh Hemmelder, Mickaël Jc Hiligsmann, Wanda S Konijn, Magda M van Loon, José Mc Maessen, Barend Me Mees, Joris I Rotmans iD und 3 weitere

The Journal of Vascular Access · 2024

DOI: 10.1177/11297298231212754 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Vascular Access, 2024. Verfasst von Bianca Zomer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Blood Vessel Prosthesis Implantation, Graft Occlusion, Vascular, Regional Blood Flow. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

It is assumed that identification and correction of asymptomatic stenoses in the vascular access circuit will prevent thrombosis that would require urgent intervention to continue hemodialysis treatment. However, the evidence base for this assumption is limited. Recent international clinical practice guidelines reach different conclusions on the use of surveillance for vascular access flow dysfunction and recommend further research to inform clinical practice.

Methods

The FLOW trial is a double-blind, multicenter, randomized controlled trial with a 1:1 individual participant treatment allocation ratio over two study arms. In the intervention group, only symptomatic vascular access stenoses detected by clinical monitoring are treated, whereas in the comparison group asymptomatic stenoses detected by surveillance using monthly dilution flow measurements are treated as well. Hemodialysis patients with a functional arteriovenous vascular access are enrolled. The primary outcome is the access-related intervention rate that will be analyzed using a general linear model with Poisson distribution. Secondary outcomes include patient satisfaction, access-related serious adverse events, and quality of the surveillance process. A cost effectiveness analysis and budget impact analysis will also be conducted. The study requires 828 patient-years of follow-up in 417 participants to detect a difference of 0.25 access-related interventions per year between study groups.

Discussion

As one of the largest randomized controlled trials assessing the clinical impact of vascular access surveillance using a strong double-blinded study design, we believe the FLOW trial will provide much-needed evidence to improve vascular access care for hemodialysis patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalBlood Vessel Prosthesis ImplantationGraft Occlusion, VascularRegional Blood FlowRenal DialysisVascular PatencyHumansBlood Flow VelocityBlood Vessel ProsthesisCost-Benefit AnalysisDouble-Blind MethodMulticenter Studies as TopicPredictive Value of TestsRandomized Controlled Trials as TopicTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Vascular accessfollow uphemodialysismonitoringsurveillance

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands.
  • Department of Vascular Surgery, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands.
  • Kennisinstituut, Federation Medical Specialists, Utrecht, The Netherlands.
  • Department of Clinical Epidemiology, Leids University Medical Centre, Leiden, The Netherlands.
  • Department of Radiology, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands.
  • Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, Limburg, The Netherlands.

ORCID-Profile: Bianca Zomer, Matthijs S Ruiter, Joris I Rotmans, Maarten Gj Snoeijs

Förderung

  • ZonMw

Zitieren

APA

Zomer, B., Ruiter, M. S., Dekker, F. W., Goertz, E. G., de Haan, M. W., Hemmelder, M. H., Hiligsmann, M. J., Konijn, W. S., van Loon, M. M., Maessen, J. M., Mees, B. M., Rotmans, J. I., Schurink, G. W., Vleugels, M. J., & Snoeijs, M. G. (2024). FLOW: Flow dysfunction of hemodialysis vascular access: A randomized controlled trial on the effectiveness of surveillance of arteriovenous fistulas and grafts. The Journal of Vascular Access. https://doi.org/10.1177/11297298231212754

Vancouver

Zomer B, Ruiter MS, Dekker FW, Goertz EG, de Haan MW, Hemmelder MH, et al. FLOW: Flow dysfunction of hemodialysis vascular access: A randomized controlled trial on the effectiveness of surveillance of arteriovenous fistulas and grafts. The Journal of Vascular Access. 2024. doi:10.1177/11297298231212754

BibTeX
@article{Zomer2024,
  author = {Zomer, Bianca and Ruiter, Matthijs S and Dekker, Friedo W and Goertz, Ellen Gd and de Haan, Michiel W and Hemmelder, Marc Hh and Hiligsmann, Mickaël Jc and Konijn, Wanda S and van Loon, Magda M and Maessen, José Mc and Mees, Barend Me and Rotmans, Joris I and Schurink, Geert Wh and Vleugels, Marie-José Jpj and Snoeijs, Maarten Gj},
  title = {FLOW: Flow dysfunction of hemodialysis vascular access: A randomized controlled trial on the effectiveness of surveillance of arteriovenous fistulas and grafts},
  journal = {The Journal of Vascular Access},
  year = {2024},
  doi = {10.1177/11297298231212754}
}
Kostenlos starten →